| Author (Corporate) | Council of the European Union: General Secretariat |
|---|---|
| Series Title | Press Release |
| Series Details | PRES/14/250 (08.05.14) |
| Publication Date | 08/05/2014 |
| Content Type | News |
|
On 8 May 2014, the Council approved a draft regulation aimed at ensuring the funding of strengthened post-authorisation monitoring of medicines for human use ("pharmacovigilance") conducted at EU level. That followed a first-reading agreement reached with the European Parliament in February 2014. The EU rules on pharmacovigilance had been reinforced in 2010 and, following the Mediator case, in 2012. The agreement endorsed that day was expected to provide the means to finance the work of addressing the safety concerns and maintain high standards of quality, safety and efficacy of medicinal products. |
|
| Source Link | Link to Main Source http://www.consilium.europa.eu/uedocs/cms_data/docs/pressdata/en/lsa/142527.pdf |
| Related Links |
|
| Subject Categories | Business and Industry, Health |
| Countries / Regions | Europe |
